Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0451641 (
urolithiasis
)
3,973
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The work shows the economical effect of concurrent surgery on the abdominal organs and organs of the retroperitoneal space undertaken in 404 patients whose ages ranged from 16 to 81. The time taken by the concurrent operations and the duration of treatment at the hospital were studied. In 63.1% of patients the concurrent operations lasted up to 3 hours. The duration of treatment was least in concurrent appendectomy (14.2 +/- 0.5 days) and longest on oncological patients (40.9 +/- 2.2 days). It is noted that the sum terms of treatment reduce, while in separate performance of the operations they are prolonged. The highest economy of finances is noted in
urolithiasis
,
nephroptosis
, acute appendicitis, hernias, and cholelithiasis. The national economic effect in the treatment of 404 patients at the clinic came to 60,471 rubles and 18 kopecks.
...
PMID:[Combined operations as a method for increasing the capacity of a surgical clinic]. 144 85
Excretory urography was performed in 55 patients with non-specific ulcerative colitis and Crohn's disease with colonic involvement. The kidney pathology was revealed in 47.3% of the patients, in 5 (27.8%) of 18 patients examined before the operation, and in 21 (56.8%) of 37--after extensive colonic resection.
Nephroptosis
,
urolithiasis
, hydronephrosis, pyelocystitis were the main complications.
...
PMID:[Clinico-radiologic features of the kidneys in patients with nonspecific colitis]. 234 53
Health examination of events in the Evenki Autonomic Region and events in Yakutia using multiprofile questionnaires revealed high incidence of renal diseases: chronic pyelonephritis, chronic cystitis,
nephroptosis
. The former occurs most frequently, runs in association with
nephroptosis
and chronic cystitis, affects females more frequently than males.
Nephroptosis
is attributed to a nomad's life which the natives lead. In spite of high urinary oxalates and urates levels,
urolithiasis
in the Northerners occurs relatively seldom.
...
PMID:[The epidemiology of the most prevalent kidney diseases in the nationalities of the North]. 816 Mar 13
A novel difluoroquinolone drug sparfloxacine has a wide antibacterial spectrum. It is active both against gram-negative and gram-positive flora. Sparfloxacine was tried in 43 patients with pyelonephritis and prostatitis complicated with
urolithiasis
, diabetes mellitus,
nephroptosis
, anomalous kidneys, etc. The drug was given according to its pharmacokinetics for 7-14 days in a daily dose 400 mg (day 1) then 200 mg/day. The effectiveness of sparfloxacine in complicated pyelonephritis and prostatitis was rather high: clinical response reached 83.7%, bacteriological one--78.7%.
...
PMID:[Effectiveness of sparfloxacin (sparflo) in the treatment of complicated forms of pyelonephritis and prostatitis]. 1189 27
The authors review the effectiveness of a novel fluoroquinolone drug sparfloxacine (Sparflo, Dr. Reddy's Laboratories) in the treatment of patients with complicated forms of pyelonephritis and prostatitis. Both gramnegative and grampositive agents causing complicated urologic infections were highly sensitive to sparfloxacine: Enterobacter spp.--40.8%, Pseudomonas aeruginosa--38.5%, Proteus spp.--42.6%, E. coli--91.4%, Staphylococcus spp.--80.0%, Enterococcus faecalis--21.4%. Sparfloxacine was used in the treatment of 43 patients with complicated pyelonephritis and prostatitis. The complicating factors were the following:
urolithiasis
, renal anomalies, hydronephrotic transformation,
nephroptosis
, benign prostatic hyperplasia. Clinical response reached 83.7%; microbiological--78.7%. Thus, sparfloxacin has a wide spectrum of antibacterial activity and can be effectively used in patients with complicated infections of the urinary tract.
...
PMID:[Use of sparfloxacin (Sparflo) in treating complicated urologic infections]. 1207 17